Exact Sciences' Asset Sale to Genzyme to Bring in $24.5M

The asset sale and equity investment by Genzyme ended Sequenom's bid to acquire Exact Sciences.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.